https://stock.noler.com/us/stock/audentes-therapeutics-inc https://stock.noler.com/us/stock/audentes-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/audentes-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/audentes-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/audentes-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/audentes-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/audentes-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/audentes-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/audentes-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/audentes-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/audentes-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/audentes-therapeutics-inc/aoci https://stock.noler.com/us/stock/audentes-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/audentes-therapeutics-inc/asset-retirement-obligation https://stock.noler.com/us/stock/audentes-therapeutics-inc/asset-retirement-obligation-accretion-expense https://stock.noler.com/us/stock/audentes-therapeutics-inc/asset-retirement-obligation-change https://stock.noler.com/us/stock/audentes-therapeutics-inc/asset-retirement-obligation-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/asset-retirement-obligation-liabilities-incurred https://stock.noler.com/us/stock/audentes-therapeutics-inc/asset-retirement-obligations-noncurrent https://stock.noler.com/us/stock/audentes-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-unrealized-loss-position-fair-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-unrealized-loss-position-loss https://stock.noler.com/us/stock/audentes-therapeutics-inc/available-for-sale-unrealized-loss-position-twelve-months-or-longer-fair-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/audentes-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/audentes-therapeutics-inc/capital-lease-obligations https://stock.noler.com/us/stock/audentes-therapeutics-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/audentes-therapeutics-inc/cash https://stock.noler.com/us/stock/audentes-therapeutics-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/audentes-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/audentes-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/audentes-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/audentes-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/audentes-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/audentes-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/audentes-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/audentes-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/audentes-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/common-stock-value-outstanding https://stock.noler.com/us/stock/audentes-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/audentes-therapeutics-inc/construction-payable-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/contractual-obligation https://stock.noler.com/us/stock/audentes-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/audentes-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/audentes-therapeutics-inc/current-assets https://stock.noler.com/us/stock/audentes-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-rent-credit https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/audentes-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/audentes-therapeutics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/audentes-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/audentes-therapeutics-inc/dividends-common-stock-cash https://stock.noler.com/us/stock/audentes-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/audentes-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/audentes-therapeutics-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/audentes-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/audentes-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/audentes-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/audentes-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/audentes-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/audentes-therapeutics-inc/goodwill https://stock.noler.com/us/stock/audentes-therapeutics-inc/hosting-arrangement-service-contract-implementation-cost-capitalized-before-accumulated-amortization https://stock.noler.com/us/stock/audentes-therapeutics-inc/hosting-arrangement-service-contract-implementation-cost-expense-amortization https://stock.noler.com/us/stock/audentes-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/audentes-therapeutics-inc/income-tax https://stock.noler.com/us/stock/audentes-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/audentes-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/audentes-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/audentes-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/audentes-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/audentes-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/audentes-therapeutics-inc/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/audentes-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/audentes-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/audentes-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/audentes-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/audentes-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/audentes-therapeutics-inc/investment-income-amortization-of-discount https://stock.noler.com/us/stock/audentes-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/audentes-therapeutics-inc/investment-income-net https://stock.noler.com/us/stock/audentes-therapeutics-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/audentes-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/audentes-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/audentes-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/audentes-therapeutics-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/audentes-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/audentes-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/audentes-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/audentes-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/audentes-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/audentes-therapeutics-inc/net-income https://stock.noler.com/us/stock/audentes-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/audentes-therapeutics-inc/number-of-reporting-units https://stock.noler.com/us/stock/audentes-therapeutics-inc/oci-before-tax https://stock.noler.com/us/stock/audentes-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/audentes-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-income https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/audentes-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/audentes-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/other-long-term-debt https://stock.noler.com/us/stock/audentes-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/audentes-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/audentes-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/audentes-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/audentes-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/audentes-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/audentes-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/audentes-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/audentes-therapeutics-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/audentes-therapeutics-inc/preferred-stock-dividends-per-share-declared https://stock.noler.com/us/stock/audentes-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/audentes-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/audentes-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/audentes-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/audentes-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/audentes-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/audentes-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/audentes-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/audentes-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/audentes-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/audentes-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/audentes-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/audentes-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/audentes-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/audentes-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/audentes-therapeutics-inc/public-float https://stock.noler.com/us/stock/audentes-therapeutics-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/audentes-therapeutics-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/audentes-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/audentes-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/audentes-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/audentes-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/audentes-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/audentes-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/audentes-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/audentes-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/audentes-therapeutics-inc/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-shares-issued-shares-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/audentes-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/audentes-therapeutics-inc/straight-line-rent https://stock.noler.com/us/stock/audentes-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/audentes-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/audentes-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/audentes-therapeutics-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/audentes-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/audentes-therapeutics-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/audentes-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/audentes-therapeutics-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/audentes-therapeutics-inc/total-assets https://stock.noler.com/us/stock/audentes-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/audentes-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/audentes-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/audentes-therapeutics-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/audentes-therapeutics-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/audentes-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/audentes-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/audentes-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted